Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-01

Clinical Trial Update: Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Clinical trial update evaluating the safety and efficacy of Shenyankangfu Tablets for chronic kidney disease in a Phase 4 study. The current status of results i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shenyankangfu Tablets

Snippet

Sponsor: Chen Xiangmei | Conditions: Chronic Kidney Disease | Phase 4 | Status: UNKNOWN